Teladoc Health Announces Chief Financial Officer Transition

Core Insights - Teladoc Health announced the resignation of Chief Financial Officer Mala Murthy, who will leave the company on November 21, 2025, to pursue an opportunity outside the healthcare industry [1][2] - The company reaffirmed its full-year 2025 consolidated revenue and adjusted EBITDA outlook, with preliminary results for Q3 2025 showing consolidated revenue of $626.4 million and adjusted EBITDA of $69.9 million [3][5] Leadership Changes - Mala Murthy will continue in her role until her departure and will present during the company's Q3 earnings conference call [2] - An interim leadership structure will be established during the search for a new CFO, with key finance leaders reporting to CEO Chuck Divita [2][3] Financial Performance - For the three months ended September 30, 2025, Teladoc Health reported a consolidated revenue of $626.4 million and an adjusted EBITDA of $69.9 million [3][18] - The adjusted EBITDA for the same period reflects a decrease from $83.3 million in Q3 2024, indicating a year-over-year decline [18] Upcoming Events - The company will host a conference call on October 29, 2025, to discuss its Q3 2025 financial results, with a news release and presentation materials to be issued prior to the call [4]